QUARZAN Drug Patent Profile
✉ Email this page to a colleague
When do Quarzan patents expire, and what generic alternatives are available?
Quarzan is a drug marketed by Roche and is included in one NDA.
The generic ingredient in QUARZAN is clidinium bromide. There are seven drug master file entries for this compound. Additional details are available on the clidinium bromide profile page.
Summary for QUARZAN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 71 |
Patent Applications: | 1,284 |
Formulation / Manufacturing: | see details |
DailyMed Link: | QUARZAN at DailyMed |
US Patents and Regulatory Information for QUARZAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Roche | QUARZAN | clidinium bromide | CAPSULE;ORAL | 010355-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Roche | QUARZAN | clidinium bromide | CAPSULE;ORAL | 010355-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |